HK1162526A1 - 衍生物及其應用 - Google Patents
衍生物及其應用Info
- Publication number
- HK1162526A1 HK1162526A1 HK12102651.2A HK12102651A HK1162526A1 HK 1162526 A1 HK1162526 A1 HK 1162526A1 HK 12102651 A HK12102651 A HK 12102651A HK 1162526 A1 HK1162526 A1 HK 1162526A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- glp
- derivatives
- Prior art date
Links
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010246866 | 2010-08-06 | ||
CN201110078528 | 2011-03-30 | ||
PCT/CN2011/000765 WO2012016419A1 (zh) | 2010-08-06 | 2011-04-29 | Glp-1衍生物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1162526A1 true HK1162526A1 (zh) | 2012-08-31 |
Family
ID=45558923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12102651.2A HK1162526A1 (zh) | 2010-08-06 | 2012-03-16 | 衍生物及其應用 |
Country Status (2)
Country | Link |
---|---|
HK (1) | HK1162526A1 (zh) |
WO (1) | WO2012016419A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9764003B2 (en) | 2012-07-01 | 2017-09-19 | Novo Nordisk A/S | Use of long-acting GLP-1 peptides |
CA3078652A1 (en) | 2017-10-12 | 2019-04-18 | Novo Nordisk A/S | Semaglutide in medical therapy |
RS63523B1 (sr) | 2018-04-05 | 2022-09-30 | Sun Pharmaceutical Ind Ltd | Novi glp-1 analozi |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA24129A1 (fr) * | 1996-08-30 | 1997-10-01 | Novozymes As | Procede pour deformer une matiere textile cellulosique |
TWI362392B (en) * | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
CA2596926A1 (en) * | 2005-03-18 | 2006-09-21 | Novo Nordisk A/S | Extended glp-1 compounds |
-
2011
- 2011-04-29 WO PCT/CN2011/000765 patent/WO2012016419A1/zh active Application Filing
-
2012
- 2012-03-16 HK HK12102651.2A patent/HK1162526A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012016419A1 (zh) | 2012-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
HK1206004A1 (zh) | 巨大戟二萜醇- -酰化物 和巨大戟二萜醇- -氨基甲酸酯 | |
HK1187049A1 (zh) | 雙芳基連接的芳基三唑酮及其用途 | |
EP2552953A4 (en) | FRIZZLED-BINDING SUBSTANCES AND ITS USES | |
ZA201208173B (en) | Peptices and their use | |
HRP20160922T1 (hr) | Oligopeptidni spojevi i njihove uporabe | |
ZA201303773B (en) | Compounds and their use | |
HRP20182083T1 (hr) | Nova kombinacija i uporaba | |
EP2575453A4 (en) | OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE | |
EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
EP2529013A4 (en) | NOVEL BETA GLUCOSIDASE AND USES THEREOF | |
EP2615094A4 (en) | SESTERTERPEN COMPOUNDS AND THEIR USE | |
HK1162526A1 (zh) | 衍生物及其應用 | |
EP2638160A4 (en) | NUCLIONS AND RIBOCAPSIDES | |
GB201014319D0 (en) | Compounds and uses thereof | |
GB201020848D0 (en) | Compounds and their use | |
GB201018028D0 (en) | Compounds and their use | |
GB201017822D0 (en) | Compounds and their use | |
GB201005511D0 (en) | Compounds and their use | |
GB201002337D0 (en) | Compounds and their use | |
GB201000309D0 (en) | Compounds and their use | |
GB201000305D0 (en) | Compounds and their use | |
GB201000307D0 (en) | Compounds and their use | |
GB201000308D0 (en) | Compounds and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230501 |